Tafero EM Tablet

Composition:

Tenofovir Alafenamide 25mg + Emtricitabine 200mg

About Tafero EM Tablet

Tenofovir alafenamide and Emtricitabine are HIV nucleoside analog reverse transcriptase inhibitors and are indicated as an FDC with other antiretroviral agents for the treatment of HIV-1. FDC of Tenofovir alafenamide and Emtricitabine is indicated in combination with other antiretroviral agents for treatment of HIV-1 infections in adults and adolescents with age 12 years and older.

Tafero EM Tablet

*To be consumed as directed by physician.


Usage Instructions

Sustained efficacy observed with TAF after the switch from TDF, Effective therapy achieved at 90% lower systemic exposure to TFV and Improved renal and bone safety with TAF.